S-23 ZPHC — 10 mg (100 Tablets × 10 mg)

S-23 ZPHC Overview

S-23 ZPHC — 10 mg (100 tablets × 10 mg) is a product associated with S-23, a compound classified as a selective androgen receptor modulator (SARM). S-23 has attracted attention in online bodybuilding and research communities because of its interaction with androgen receptors and its history of investigation in preclinical research.

For readers researching S-23, ZPHC, S-23 10 mg tablets, SARMs, and S-23 research, it is important to distinguish investigational compounds from FDA-approved medicines. The U.S. Food and Drug Administration identifies S-23 as a SARM and states that SARMs are not approved for human use.

This page is intended to provide factual product information and search-friendly educational content rather than instructions for human use.

What Is S-23?

S-23 is a synthetic compound belonging to the selective androgen receptor modulator class. SARMs were developed as research compounds intended to investigate whether androgen-receptor activity could be targeted more selectively than with conventional anabolic-androgenic steroids.

S-23 has consequently become a frequently searched term among people researching experimental androgen-receptor compounds. Searches such as “S-23 10 mg,” “S-23 ZPHC,” “S-23 tablets,” “ZPHC S-23,” and “SARM S-23” commonly reflect interest in the identity, formulation, and research background of the compound.

However, online descriptions can sometimes blur the distinction between laboratory research and approved medical use. According to the FDA, products marketed as SARMs—including S-23—are unapproved new drugs when marketed for human use.

S-23 ZPHC Product Format

The listed product format is:

• Product: S-23 ZPHC
• Strength: 10 mg
• Quantity: 100 tablets
• Stated total amount: 1,000 mg
• Category: SARM / investigational compound
• Primary keyword: ZPHC
• Related keywords: S-23, S-23 10 mg, S-23 tablets, ZPHC S-23, SARM research, selective androgen receptor modulator

The stated quantity of 100 tablets at 10 mg each corresponds mathematically to 1,000 mg of labeled material in the package. That packaging information should not be interpreted as a recommendation for dosage or human administration.

Why S-23 Receives Research Interest

S-23 is discussed in scientific and research contexts because it interacts with androgen receptors. SARMs are designed around the concept of selectively influencing androgen-receptor signaling in particular tissues.

This area of research has generated interest because researchers have investigated whether selective androgen-receptor activity could eventually provide useful therapeutic applications. Nevertheless, investigational research should not be confused with established clinical treatment.

The FDA specifically warns that SARMs are not FDA-approved and has reported adverse events associated with SARM products. Reported concerns include liver injury and increased risks involving cardiovascular health.

Important Safety Information

The most important consideration when researching S-23 ZPHC is its regulatory and safety status.

S-23 is not an FDA-approved medication for human use. The FDA has specifically listed S-23 among substances associated with SARMs and has stated that SARMs marketed for human use are unapproved drugs.

The FDA also warns that SARMs may be associated with serious or potentially life-threatening adverse effects. Reported concerns include:

• Liver injury
• Increased risk of heart attack or stroke
• Sexual dysfunction
• Infertility
• Testicular shrinkage
• Sleep disturbances
• Other potentially serious adverse reactions

The FDA therefore recommends consulting a healthcare professional regarding products promoted for muscle growth or athletic performance.

This makes careful evaluation of product claims especially important. Marketing language suggesting that an investigational SARM is equivalent to an approved supplement or medication can create a misleading impression about its regulatory status.

S-23 and Athletic Competition

Competitive athletes should also be aware of anti-doping considerations. USADA identifies S-23 among SARMs and states that SARMs are prohibited under the World Anti-Doping Agency framework.

Anyone subject to drug testing should independently verify the current prohibited-substance rules applicable to their sport, organization, and competition level before considering any investigational compound.

Understanding ZPHC S-23 Product Information

When evaluating an S-23 ZPHC 10 mg listing for research purposes, useful information to examine includes the stated compound identity, concentration, lot information, packaging, analytical documentation, and applicable regulatory disclaimers.

A responsible product-information page should avoid unsupported claims about guaranteed muscle growth, fat loss, strength increases, hormone optimization, or athletic performance.

Independent laboratory documentation can be useful for understanding identity and analytical characteristics, but laboratory testing does not transform an investigational substance into an FDA-approved medicine.

S-23 Research and Responsible Information

Interest in S-23 research continues partly because SARMs represent an important area of pharmacological investigation. Researchers have examined androgen-receptor modulation as a potential route toward tissue-selective effects.

At the same time, the FDA’s position is clear: SARMs have not been approved for human use, and products marketed as SARMs should not be represented as ordinary dietary supplements.

This distinction is particularly important for consumers searching Google for terms such as “where to buy S-23,” “S-23 ZPHC,” “ZPHC S-23 10 mg,” or “S-23 tablets USA.” Search visibility does not establish safety, legality, effectiveness, or FDA approval.

Frequently Asked Questions

What is S-23?

S-23 is a synthetic selective androgen receptor modulator associated with investigational research into androgen-receptor activity.

Is S-23 FDA approved?

No. The FDA states that S-23 is among SARMs that are not approved for human use.

How many tablets are listed in S-23 ZPHC 10 mg?

The specified product format contains 100 tablets, with each tablet listed as containing 10 mg, for a stated total of 1,000 mg.

Is S-23 a dietary supplement?

No. The FDA states that SARMs are not legitimate dietary supplement ingredients and are not approved dietary supplements.

Is S-23 prohibited for athletes?

USADA identifies S-23 among SARMs and states that SARMs are prohibited under the WADA Prohibited List framework.

Is S-23 safe for human use?

S-23 has not been FDA-approved for human use. FDA warnings concerning SARMs describe potentially serious health risks, so it should not be presented as an established safe human-use product.

Final Considerations

S-23 ZPHC — 10 mg (100 tablets × 10 mg) is best understood as an investigational SARM-associated product rather than an FDA-approved medicine or conventional dietary supplement. Its research background explains why it receives significant online interest, but that interest should not be confused with established safety or clinical approval.

For anyone researching ZPHC, S-23 10 mg, S-23 tablets, S-23 SARMs, or selective androgen receptor modulators, the strongest approach is to evaluate regulatory information, independent analytical evidence, and established scientific literature rather than relying solely on promotional claims.

The FDA’s published safety communications provide an important counterpoint to aggressive online marketing, particularly because SARMs have been associated with potentially serious adverse effects and are not approved for human use.